Prenatal immune challenge disrupts sensorimotor gating in adult rats: Implications for the etiopathogenesis of schizophrenia

Neuropsychopharmacology

Volumn 26, Issue 2, 2002, Pages 204-215

  Borrell, José ^a   Vela, José Miguel ^b   Arévalo Martin, Angel ^a   Molina Holgado, Eduardo ^a   Guaza, Carmen ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antipsychotics; Cytokines; Immune challenge; Prepulse inhibition; Rat; Schizophrenia

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CLOZAPINE; CORTICOSTERONE; HALOPERIDOL; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TYROSINE 3 MONOOXYGENASE;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNE SYSTEM; IMMUNOREACTIVITY; MALE; NONHUMAN; PATHOGENESIS; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CORTICOSTERONE; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, MHC CLASS I; IMMUNITY; INTERLEUKIN-2; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PREGNANCY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SCHIZOPHRENIA; STARTLE REACTION; TYROSINE 3-MONOOXYGENASE;

EID: 0036150201     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00360-8     Document Type: Article

References (68)

1. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia: An analysis of Scottish, English, and Danish data
2. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
3. Bacterial toxin-induced cytokine production studied at the single-cell level
4. Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
5. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: Interaction with the cholinergic system
6. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia
7. Reversal of isolation rearing-induced deficits in prepulse inhibition by seroquel and olanzapine
8. Penetration of interleukin-6 across the murine blood-barrier
9. Evidence for activation of microglia in patients with psychiatric illnesses
10. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells
11. Corticotrophin-releasing factor-producing neurons in the rat activated by interleukin-1
12. Immunoregulatory feed-back between interleukin-1 and glucocorticoid hormones
13. On the effect of neonatal nitric oxide synthase inhibition in rats: A potential neurodevelopmental model of schizophrenia
14. Prestimulus effects on human startle reflex in normalise and schizophrenics in normals
15. Microglial-neuronal interactions in synaptic damage and recovery
16. IL-2 increases CRF secretion from superfused rat hypothalami. Influence of glucocorticoids
17. Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: Disruption by apomorphine
18. Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
19. Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF
20. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
21. Potentiation of prepulse inhibition of the startle reflex in rats: Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity
22. Interleukin-1 and the pathogenesis of the acute-phase response
23. The effects of an early stressful life event on sensorimotor gating in adult rats
24. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice
25. Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
26. Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected
27. Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder
28. Neurotoxic consequences of central long-term administration of interleukin-2 in rats
29. Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input
30. Sickness behavior as a new target for drug development
31. Decreased interleukin-2 production in Korean schizophrenic patients
32. Infection and autoimmunity as etiologic factors in schizophrenia: A Review and Reappraisal
33. Normalization of information processing deficits in schizophrenia with clozapine
34. Local administration of recombinant human interleukin-1β in the rat hippocampus increases serotoninergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature
35. Effect of bacterial endotoxin and Interleukin 1-β on hippocampal serotoninergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study
36. To model a psychiatric disorder in animals. Schizophrenia as a reality test
37. Sex differences in age of onset of schizophrenia
38. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression
39. Dopaminergic stimulation disrupts sensorimotor gating in the rat
40. Adult schizophrenia following prenatal exposure to an influenza epidemic
41. Endotoxin administration induces differential neurochemical activation of the rat brain stem nuclei
42. Effects of family history and place and season of birth on the risk of schizophrenia
43. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic
44. Cytokine receptors on glial cells
45. Interleukin-2 suppresses afferent sensory transmission in the primary somatosensory cortex
46. Tumor necrosis factor-α and interleukin-2 differentially affect hippocampal serotoninergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat
47. Immunoregulators in the nervous system
48. Influence of endotoxin on nocturnal sleep in humans
49. Inflammatory cytokines: Putative regulators of neuronal and neuro-endocrine function
50. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
51. Schizophrenia as a developmental disorder of the cerebral cortex
52. Neonatal cytomegalovirus decreases prepulse inhibition in adult rats: Implications for schizophrenia
53. Cytokines and the nervous system: II. Action and mechanisms of action
54. Induction of interleukin-2 receptor in mouse microglia
55. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain
56. Sensory gating in rats depleted of dopamine as neonates: Potential relevance to findings in schizophrenic patients
57. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
58. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
59. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington' s disease
60. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
61. Cross-species studies of sensorimotor gating of the startle reflex
62. Seasonality of schizophrenic births in the United States
63. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
64. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system
65. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients
66. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia
67. Interleukin-2 and -6 induce behavioral-activating effects in mice
68. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives